DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Hortobagyi GN, Stemmer SM, Burris HA. et al.
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Ann Oncol 2018;
29: 1541-1547 . doi:10.1093/annonc/mdy155
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.